Patients with refractory CMV infection following allo-HSCT are at high risk for CMV disease and non-relapse mortality.

Liu J, Kong J, Chang YJun, Chen H, Chen YHong, Han W, Wang Y, Yan CHua, Wang JZhi, Wang FRong, et al. Patients with refractory CMV infection following allo-HSCT are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect. 2015.